![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/31/2891596/0/en/OPKO-Health-to-Participate-in-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/07/2877206/0/en/OPKO-Health-Reports-First-Quarter-2024-Business-Highlights-and-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/03/2875075/0/en/OPKO-Health-to-Report-First-Quarter-2024-Financial-Results-on-May-7-2024.html
https://www.globenewswire.com//news-release/2024/03/05/2840482/0/en/AIDS-Clinical-Trial-Group-Presents-Results-from-Phase-1-Study-of-ModeX-Trispecific-Antibody-for-the-Treatment-and-Prevention-of-HIV.html
https://www.globenewswire.com//news-release/2024/02/27/2836449/0/en/OPKO-Health-Reports-Fourth-Quarter-2023-Business-Highlights-and-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/22/2834071/0/en/OPKO-Health-to-Report-Fourth-Quarter-2023-Financial-Results-on-February-27-2024.html
https://www.globenewswire.com//news-release/2024/01/09/2806678/0/en/OPKO-Health-Announces-Closing-of-Private-Offering-of-230-Million-Convertible-Senior-Notes-Due-2029-including-Full-Exercise-of-Initial-Purchaser-s-Option-to-Purchase-Additional-Note.html
https://www.globenewswire.com//news-release/2024/01/08/2805414/0/en/OPKO-Health-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/01/03/2803661/0/en/OPKO-Health-Announces-Private-Offering-of-Convertible-Senior-Notes-Due-2029.html
https://www.globenewswire.com//news-release/2023/11/06/2774514/0/en/OPKO-Health-Reports-Third-Quarter-2023-Business-Highlights-and-Financial-Results.html